BioWorld

June 6, 2002

View Archived Issues

Waksal Subpoenaed; ImClone To Face House Subcommittee

WASHINGTON - Former ImClone Systems Inc. CEO Samuel Waksal has been subpoenaed by a House subcommittee to answer questions surrounding the business transactions and development of the investigational cancer drug Erbitux. (BioWorld Today) Read More

Battered' Market Prompts LSB To Reduce Staff, Shift Resources

Read More

Lab-Grown Cholera Bacteria No Match For Natural Stool Germs, In In Vivo-In Silico Competition

Read More

LION Plans To Narrow Focus, Unload Drug Discovery Unit

Read More

TransForm, ALZA Sign Deal For Transdermal Products

Read More

Other News To Note

Read More